Meeting
2021 ASCO Annual Meeting
Heterogeneity of HER2 expression in circulating tumor cells of patients with breast cancer brain metastases and impact on brain disease control.
Authors
Douglas Guedes Castro
A.C. Camargo Cancer Center, São Paulo, Brazil
Douglas Guedes Castro , Antonio Cassio Assis Pellizzon , Alexcia Camila Braun , Michael Jenwei Chen , Maria Leticia Gobo Silva , Ricardo Fogaroli , Guilherme Rocha Melo Gondim , Henderson Ramos , Elson Santos Neto , Carolina Humeres Abrahao , Liao Shin Yu , Emne Ali Abdallah , Vinicius Fernando Calsavara , Ludmilla T.D. Chinen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2029)
DOI
10.1200/JCO.2021.39.15_suppl.2029
Abstract #
2029
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinical and pathological characteristics of breast cancer with resected brain metastasis.
First Author: Shiyuan Anabeth Liu
Poster
2015 ASCO Annual Meeting
Correlation of trastuzumab treatment benefit with quantitative HER2 expression levels in HER2 positive metastatic breast cancer.
First Author: Beatrice Bachmeier
Poster
2011 Breast Cancer Symposium
Role of HER2 status in the treatment of brain metastases arising from breast cancer by stereotactic radiosurgery.
First Author: Y. Novik
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The expanded indications of HER2-targeted therapies by monitoring of circulating tumor cells.
First Author: Yasuaki Kimura